N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development
- PMID: 8747759
- DOI: 10.1016/0893-133X(95)00083-P
N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development
Abstract
This laboratory perspective reviews the pharmagologic approaches that have been used in preclinical animal models to demonstrate the ability of competitive (LY274614) and noncompetitive (MK801 and dextromethorphan) N-methyl-D-aspartate (NMDA) receptor antagonists to attenuate or reverse the development of morphine tolerance. We provide additional data to support previous observations that these NMDA antagonists modulate morphine (mu) opioid tolerance but do not affect U50488H (kappa 1) opioid tolerance. A strategy, which utilizes efficacy as an NMDA receptor antagonist and clinical safety, provides the basis for a discussion of the clinical potential of dextromethorphan, ketamine, and felbamate as modulators of opioid tolerance in pain patients or opioid addicts. The potential use of NMDA receptor antagonists and nitric oxide synthase (NOS) inhibitors in neuropathic pain is also discussed.
Similar articles
-
The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.Pain. 1994 Jan;56(1):69-75. doi: 10.1016/0304-3959(94)90151-1. Pain. 1994. PMID: 7512709
-
The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction.Neuropsychopharmacology. 1995 Dec;13(4):269-93. doi: 10.1016/0893-133X(95)00140-9. Neuropsychopharmacology. 1995. PMID: 8747752 Review.
-
Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.Pharmacol Biochem Behav. 2002 Dec;74(1):73-86. doi: 10.1016/s0091-3057(02)00961-9. Pharmacol Biochem Behav. 2002. PMID: 12376154
-
Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance.Neuropsychopharmacology. 1995 Dec;13(4):309-13. doi: 10.1016/0893-133X(95)00084-Q. Neuropsychopharmacology. 1995. PMID: 8747755 Review.
-
The role of nitric oxide in the development of morphine tolerance in rat hippocampal slices.Eur J Pharmacol. 1999 Oct 27;383(2):129-35. doi: 10.1016/s0014-2999(99)00561-0. Eur J Pharmacol. 1999. PMID: 10585526
Cited by
-
Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience.ILAR J. 2011;52(3):329-41. doi: 10.1093/ilar.52.3.329. ILAR J. 2011. PMID: 23382147 Free PMC article. Review.
-
Advances in cancer pain management.Curr Pain Headache Rep. 2001 Jun;5(3):265-71. doi: 10.1007/s11916-001-0041-y. Curr Pain Headache Rep. 2001. PMID: 11309214 Review.
-
The role of NMDA receptor antagonists in nicotine tolerance, sensitization, and physical dependence: a preclinical review.Yonsei Med J. 2008 Apr 30;49(2):175-88. doi: 10.3349/ymj.2008.49.2.175. Yonsei Med J. 2008. PMID: 18452252 Free PMC article. Review.
-
Search for the "ideal analgesic" in pain treatment by engineering the mu-opioid receptor.IUBMB Life. 2010 Feb;62(2):103-11. doi: 10.1002/iub.292. IUBMB Life. 2010. PMID: 20039371 Free PMC article. Review.
-
Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effects.Mol Psychiatry. 2018 Mar;23(3):597-608. doi: 10.1038/mp.2017.85. Epub 2017 Apr 25. Mol Psychiatry. 2018. PMID: 28439098 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
